Gina Wang

Analyst

Barclays

Equibles does not estimate personal net worth.

About Gina Wang

Gina Wang is recorded as Analyst at Barclays. Gina Wang has spoken on 6 earnings calls across 3 companies, most recently for Cytokinetics Inc on November 5, 2025. Those appearances were for Biomarin Pharmaceutical Inc (BMRN), Vir Biotechnology, Inc. (VIR) and Cytokinetics Inc (CYTK). The companies whose calls Gina Wang spoke on are classified in the Healthcare sector.

Gina Wang on recent calls

“So, Greg, you said that now you already dosed the six cohorts. What are the thoughts when you're going to the patient population? Is the aim is to maintain area under curve over three times, you know, any upper limit you will be looking for regarding the safety.”

Analyst — Barclays, Biomarin Pharmaceutical Inc Q2 FY2025 Earnings Call · August 4, 2025

“So maybe the first one regarding the Al-Nalan decision. Did they see most up-to-date data for both HPV and HDV? and what was the reason they provided for not updating?”

Analyst — Barclays, Vir Biotechnology, Inc. Q1 FY2025 Earnings Call · May 7, 2025

“First one is regarding also the Voxogo franchise. So maybe the 333, can you help us understand because you have healthy volunteer data and mainly is a PT data.”

Analyst — Barclays, Biomarin Pharmaceutical Inc Q1 FY2025 Earnings Call · May 1, 2025

“I will ask one regarding the IKEE for your CMP franchise. I know you mentioned that you already started processing Europe. Maybe if you can provide some update there and also your strategy in the U.S. And the second question is regarding the 349AATD.”

Analyst — Barclays, Biomarin Pharmaceutical Inc Q4 FY2024 Earnings Call · February 19, 2025